Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-12-24Clinical Trial Update: Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM) [NA]
This entry notes that a clinical trial investigating the effects of monosodium glutamate on irritable bowel syndrome and fibromyalgia has co…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
A completed clinical trial led by the University of North Carolina investigated the role of intestinal inflammation in irritable bowel syndr…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: The Effects of Rifaximin Therapy in Irritable Bowel Syndrome [NA]
A completed clinical trial evaluating rifaximin for irritable bowel syndrome (IBS) conducted by Bezmialem Vakif University.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Incidence and Predictive Factor of Irritable Bowel Syndrome After Acute Diverticulitis in Korea
This completed clinical trial update from Yonsei University in Korea reports the incidence of irritable bowel syndrome after acute diverticu…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS) [Phase 2]
A Phase 2 proof-of-principle trial of TC-6499 for constipation-predominant irritable bowel syndrome has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-11-27FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for dicyclomine hydrochloride (Actavis Pharma, Inc.), updating an existing approved product.
-
FDA approval · 2013-11-27FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for dicyclomine hydrochloride submitted by Actavis Pharma, Inc., updating the approval for this gene…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide
This document reports an international, completed study evaluating quality of life in irritable bowel syndrome patients after eight weeks of…
-
FDA label_change · 2013-08-13FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for dicyclomine hydrochloride, resulting in updated labeling for Actavis Pharma’s product.
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder [Phase 4]
Phase 4 trial of the probiotic GanedenBC30 for major depressive disorder and irritable bowel syndrome was terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Mesalazine Therapy in Patients With Irritable Bowel Syndrome [Phase 3]
This document reports the completion of a Phase 3 trial evaluating mesalazine therapy in patients with irritable bowel syndrome.
-
EMA guidance · 2013-07-19Guideline on medicines for the treatment of irritable bowel syndrome released for a six-month public consultation
EMA released a guideline on medicines for the treatment of irritable bowel syndrome for a six-month public consultation.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: The Diagnostic Predictability of Food Allergy Testing [NA]
A completed clinical trial evaluating whether food allergy testing reliably predicts Irritable Bowel Syndrome outcomes. The study investigat…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Intestinal Microecology in Chronic Constipation [Phase 1]
Phase 1 clinical trial evaluating intestinal microecology in chronic constipation has completed, with irritable bowel syndrome listed as a c…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Efficacy of Probiotic Bacteria in Subjects With IBS or Functional Diarrhea/ Bloating [NA]
A completed clinical trial evaluated the efficacy of probiotic bacteria in subjects with irritable bowel syndrome or functional diarrhea.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS) [Phase 4]
This update notes the completion of a Phase 4 clinical trial evaluating controlled-release paroxetine for treating Irritable Bowel Syndrome.
-
CLINICAL_TRIALS research · 2013-05-15Clinical Trial Update: Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
A completed clinical trial update reports on factors that predict a clinical diagnosis of Irritable Bowel Syndrome in a large cohort of youn…
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome [NA]
A Mayo Clinic–sponsored clinical trial evaluating gluten intolerance in patients with diarrhea-predominant irritable bowel syndrome has comp…
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS) [Phase 2]
Phase 2 trial evaluating a cannabinoid agonist's effects on gastrointestinal and colonic motor functions in irritable bowel syndrome, with r…
-
FDA approval · 2013-04-30FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for dicyclomine hydrochloride (generic) filed by Lannett Company, Inc., approving the supplement…
-
FDA approval · 2013-04-30FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for dicyclomine hydrochloride from Aurobindo Pharma Limited, allowing a generic version to be market…
-
FDA approval · 2013-04-30FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
The FDA approved Lannett's supplemental application to market a generic dicyclomine hydrochloride product. Dicyclomine hydrochloride is used…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: Probiotics in the Treatment of Irritable Bowel Syndrome [Phase 2, Phase 3]
A Phase 2/Phase 3 study evaluating probiotics for Irritable Bowel Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: Probiotics in the Treatment of Irritable Bowel Syndrome [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating probiotics for irritable bowel syndrome was conducted, sponsored by Islamic Azad Unive…
-
FDA approval · 2013-04-19FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)
FDA supplemental application approval for Lotronex (alosetron hydrochloride) submitted by Legacy Pharma USA Inc.